Computerized Alcohol Screening for Children and Adolescents (cASCA) in Primary Care
- Conditions
- Prevention Harmful Effects
- Interventions
- Behavioral: computer-facilitated brief intervention
- Registration Number
- NCT02233946
- Lead Sponsor
- Boston Children's Hospital
- Brief Summary
The purpose of this study is to assess the psychometric properties of a brief screening questionnaire for alcohol problems among 9- to 18-year-old patients in pediatricians' offices, and to pilot test a personalized, computer-facilitated brief intervention delivered on a tablet computer and by the provider based on screening results.
- Detailed Description
The primary goal of this project is to develop a computerized screening program for primary care offices that is based on the NIAAA's new Alcohol Screening Guide for Children and Adolescents and assess its psychometric properties among nine- to 18-yr-old primary care patients. There is substantial evidence supporting the effectiveness of screening and brief intervention among adult primary care patients, primarily in the reduction of harmful drinking. However, there have been few studies of alcohol screening and brief intervention conducted among adolescents seen in busy primary care settings. This project will develop and validate a new computerized Alcohol Screening for Children and Adolescents (cASCA) program which incorporates the age-specific screening questions of the NIAAA Guide and includes the CRAFFT and AUDIT as secondary risk/problem assessments. We will add tobacco screening because tobacco use is the leading cause of cancer-related mortality in the US as well as screening for marijuana and other drug use so as to create a comprehensive screening instrument that includes all major substances that adolescents use.
Additionally, the NIAAA guide recommends that providers deliver a brief intervention in response to the screening results. Therefore, a secondary aim of this project will be to pilot-test a computer-facilitated Brief Intervention component using a randomized design comparing three groups: 1) screening with treatment as usual \[cASCA/TAU\]; 2) screening with the computer-facilitated brief intervention \[cASCA/BI\]. The BI component consists of patients viewing on the computer, immediately after the screening, their score and level of risk for a substance use problem, as well as several interactive pages of science and true-life stories about the health risks of substance use. Clinicians are then given the screen results and suggested talking points for a few minutes of brief counseling during the visit.
Hypothesis: Among 9- to 18-year-old primary care patients, those receiving cASCA/BI will have lower rates of any alcohol use, days of alcohol use, drinks per drinking day, and days of heavy episodic drinking, at 3, 6, 9 and 12-months follow-up than those receiving treatment as usual.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 871
- access to computer and email address
- available and willing to complete all follow ups by email or phone
- medically and emotionally stable
- can read and understand English
- Patient has already participated in this study
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description screening w/ computer brief intervention computer-facilitated brief intervention screening with computer-facilitated brief intervention
- Primary Outcome Measures
Name Time Method Time to First Post-visit Drinking Day 12-months follow-up Median (and interquartile range) for times to first use for the cSBI and Treatment As Usual (TAU) groups
Time to First Post-visit Heavy Episodic Drinking Day 12-months follow-up The number of days post-visit to first reported heavy episodic drinking day
- Secondary Outcome Measures
Name Time Method Time to First Post-visit Cannabis Use Day 12-months follow-up The number of days post-visit to first reported cannabis use day.
Past-3-month Riding Risk 12 months follow-up Self-reported riding in the past 3 months with a driver who had been drinking or using other drugs, stratified by reported riding risk in the past 3 months at baseline
Trial Locations
- Locations (5)
Tufts Medical Center
🇺🇸Boston, Massachusetts, United States
Boston Childrens Primary Care Center
🇺🇸Boston, Massachusetts, United States
Longwood Pediatrics
🇺🇸Boston, Massachusetts, United States
East Boston Neighborhood Health Center
🇺🇸East Boston, Massachusetts, United States
Lexington Pediatrics
🇺🇸Lexington, Massachusetts, United States